<DOC>
	<DOCNO>NCT00845728</DOCNO>
	<brief_summary>This study compare indacaterol tiotropium term bronchodilation 52 week</brief_summary>
	<brief_title>Exacerbation Study</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Male female adult age â‰¥40 year , sign Informed Consent form prior initiation studyrelated procedure Patients diagnose COPD age 40 current diagnosis severe COPD include : 1 . Smoking history least 10 pack year , current exsmokers eligible 2 . A documented history least 1 moderate severe exacerbation previous 12 month Patients receive systemic corticosteroid and/or antibiotic COPD exacerbation 6 week prior screen runin period Patients respiratory tract infection within 6 week prior screen Patients concomitant pulmonary disease Patients history asthma Patients diabetes Type I uncontrolled diabetes Type II Any patient lung cancer history lung cancer Patients history certain cardiovascular comorbid condition Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Indacaterol</keyword>
	<keyword>Tiotropium</keyword>
	<keyword>COPD</keyword>
</DOC>